Screener
Prestige Consumer Healthcare PBH Sales & Marketing
Sales & Marketing at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Prestige Consumer Healthcare in its filing.
Tagged under the XBRL concept us-gaap:MarketingAndAdvertisingExpense.
The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:15 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001295947-26-000042
| (In thousands, except per share data) | Three Months Ended June 30, 2026 | 2025 |
|---|---|---|
| Cost of sales | 129,522 | 109,199 |
| Gross profit | 136,188 | 140,331 |
| Operating Expenses | ||
| Advertising and marketing | 34,668 | 34,937 |
| General and administrative | 43,303 | 28,456 |
| Depreciation and amortization | 5,697 | 5,182 |
| Total operating expenses | 83,668 | 68,575 |
| Operating income | 52,520 | 71,756 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Prestige Consumer Healthcare's sales & marketing?
- Prestige Consumer Healthcare (PBH) reported sales & marketing of $34.67M in Q2 2026.
- How has Prestige Consumer Healthcare's sales & marketing changed year-over-year?
- Prestige Consumer Healthcare's sales & marketing decreased by 0.8% year-over-year, from $34.94M to $34.67M.
- What is the long-term trend for Prestige Consumer Healthcare's sales & marketing?
- Over 4 years (2022 to 2026), Prestige Consumer Healthcare's sales & marketing has grown at a -1.4% compound annual growth rate (CAGR), from $157.34M to $148.78M.
- What does sales & marketing mean?
- Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.
Ask your AI about Prestige Consumer Healthcare's sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude